Indiana Headlines

Topical Drug Delivery Market worth USD 205.1 billion by 2024 – New Global Report by Data Bridge Market Research

Topical Drug Delivery Market worth USD 205.1 billion by 2024 – New Global Report by Data Bridge Market Research

“Global Topical Drug Delivery Market is expected to reach at 9.2% in the forecast period 2017 to 2024”
Global Topical Drug Delivery Market, By Product Type {Topical (Solid, Liquid, Semi-Solid), Transdermal (Patches, Gels)}; End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others); Distribution Channel (Direct Tenders, Retail); Geography (North America, Europe, Asia-Pacific, Latin America, Rest of the World) – Trends and Forecast to 2024

Global topical drug delivery market is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The global topical drug delivery market is segmented on the basis of product type, indication, distribution channel, end user and geography.

On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid.

For Sample Report: Global Topical Drug Delivery Market – Trends and Forecast to 2024

The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others. In 2017, anti-acne is expected to dominate the market with the highest market share in the forecast period 2017 to 2024.

On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others. In 2017, the hospitals segment is expected to dominate the global topical drug delivery devices market with more than 40% market share.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

To read more about the scope and findings of this report visit: Global Topical Drug Delivery market is growing at a significant rate in the forecast period 2017-2024

KEY PLAYERS OPERATING IN GLOBAL TOPICAL DRUG DELIVERY MARKET:

  • Galderma Pharma, S.A.
  • Allergen Plc. Kaken Pharmaceuticals, Co., Ltd
  • Pfizer
  • Bayer AG
  • 3M
  • Hisamitsu Pharmaceuticals, Co., Inc.
  • Abbvie, Inc.
  • Valeant Pharmaceuticals
  • Antares Pharma
  • MedPharm
  • Janssen Pharmaceuticals, Inc. (A J&J Company)
  • Crescita Therapeutics
  • West Pharmaceutical Services
  • Biofarmitalia s.r.l
  • Pharmatek Laboratories, Inc.
  • Stiefel Laboratories, Inc.
  • Tapemark
  • Acrux Limited
  • Nitto Denko Corporation
  • Skinvisible Pharmaceuticals, Inc.
  • Mylan Pharmaceuticals Inc.
  • Pocono Coated Products LLC
  • TheraSolve NV.
  • Samyang Biopharmaceuticals Corporation
  • Lohmann Therapie-Systeme AG
  • Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc.
  • Novosis AG
  • Endo Pharmaceuticals Inc.
  • Transdermal Technologies, Inc.
  • Sheffield Pharmaceuticals, Inc.
  • Solvay

Some of the major factors driving the topical drug delivery market are ability to deliver drug at the desired site, inter-and intra-patient variations, without fluctuations in drug levels, an enhanced suitability for self-medication and improved compliance. Also, increasing aging population, growing prevalence of skin related ailments and rising prevalence of chronic diseases, also new and better technologies for topical drug delivery is expected to boost the growth of this market are the major factors driving the growth of the injectable drug delivery market.

Enquire about the report: Global Topical Drug Delivery Market – Trends and Forecast to 2024

Table of Content:

1. INTRODUCTION

      1.1. OVERVIEW OF THE GLOBAL TOPICAL DRUG DELIVERY MARKET

 

      1.2. MARKET SEGMENTATION & COVERAGE

 

               1.2.1. CURRENCY AND PRICING

 

               1.2.2. LIMITATION

 

               1.2.3. STAKEHOLDERS

 

2. RESEARCH METHODOLOGY

      2.1. KEY TAKEAWAYS

 

     2.2. ARRIVING AT THE GLOBAL TOPICAL DRUG DELIVERY MARKET SIZE

 

              2.2.1. MARKET CRACKDOWN APPROACH

 

              2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

 

              2.2.3. DATA TRIANGULATION

 

              2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

 

              2.2.5. PRODUCT PIPELINE ANALYSIS

 

              2.2.6. PORTER’S FIVE FORCES MATRIX

 

     2.4. GLOBAL TOPICAL DRUG DELIVERY MARKET: RESEARCH SNAPSHOT

 

     2.5. ASSUMPTIONS

 

3. MARKET LANDSCAPE SUMMARY

4. PREMIUM INSIGHTS

       4.1. OVERVIEW

 

       4.2. GLOBAL TOPICAL DRUG DELIVERY MARKET: KEY PRIMARY INSIGHTS

 

       4.3. MARKET OVERVIEW

 

                4.3.1. DRIVERS

 

                           4.3.1.1. RISING PREVALENCE OF CHRONIC DISEASE SUCH AS DIABETES

 

                           4.3.1.2. GROWTH IN TRANSDERMAL TECHNOLOGY

 

                           4.3.1.3. INNOVATION AND DEVELOPMENT OF NEW DRUG TYPES

 

                           4.3.1.4. BETTER HEALTHCARE SPENDING IN SOUTH ASIA AND AFRICA

 

                 4.3.2. RESTRAINTS

 

                 4.3.3. OPPURTUNITIES

 

                 4.3.4. THREATS

 

       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

 

5. EXECUTIVE SUMMARY

6. TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE

        6.1. OVERVIEW

 

        6.2. TOPICAL DRUG DELIVERY, BY PRODUCT TYPE

 

                 6.2.1. TRANSDERMAL DRUG DELIVERY DEVICES, BY PRODUCT TYPE

 

                            6.2.1.1. TRANSDERMAL PATCHES

 

                            6.2.1.2. TRANSDERMAL GELS

 

                           6.2.2. TOPICAL DRUG DELIVERY FORMULATIONS, BY FORM

 

                           6.2.2.1. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE

 

                           6.2.2.1.1. SOLUTIONS

 

                           6.2.2.1.2.  SUSPENSIONS

 

                           6.2.2.2.  SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE

 

                           6.2.2.2.1.  GELS

 

                           6.2.2.2.2.  CREAMS

 

                           6.2.2.2.3.  OINTMENTS

 

                           6.2.2.2.4.  PASTES

 

                           6.2.2.2.5.  LOTIONS

 

                           6.2.2.3.  SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE

 

                           6.2.2.3.1.  SUPPOSITORIES

 

                           6.2.2.3.2.  POWDERS

 

7. TOPICAL DRUG DELIVERY MARKET, BY END-USER

        7.1. OVERVIEW

 

        7.2. HOSPITALS

 

        7.3. HOME HEALTHCARE

 

        7.4. CLINICS

 

        7.5. DIAGNOSTIC CENTERS

 

        7.6. OTHERS

 

8. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

        8.1. OVERVIEW

 

       8.2. HOSPITAL PHARMACIES

 

       8.3. PHARMACY STORES

 

       8.4. DIRECT TENDERS

 

       8.5. ONLINE PHARMACY

 

9. TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY

      9.1. COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

 

              9.1.1. NORTH AMERICA

 

                         9.1.1.1. U.S.

 

                         9.1.1.2. CANADA

 

                         9.1.1.3. MEXICO

 

              9.1.2. EUROPE

 

                         9.1.2.1. GERMANY

 

                         9.1.2.2. FRANCE

 

                         9.1.2.3. U.K.

 

                         9.1.2.4. ITALY

 

                         9.1.2.5. SPAIN

 

                         9.1.2.6. RUSSIA

 

                         9.1.2.7. TURKEY

 

                         9.1.2.8. BELGIUM

 

                         9.1.2.9. NETHERLANDS

 

                         9.1.2.10. SWITZERLAND

 

                         9.1.2.11. REST OF EUROPE

 

              9.1.3. ASIA-PACIFIC (APAC)

 

                         9.1.3.1. JAPAN

 

                         9.1.3.2. CHINA

 

                         9.1.3.3. SOUTH KOREA

 

                         9.1.3.4. INDIA

 

                         9.1.3.5.  AUSTRALIA

 

                         9.1.3.6. SINGAPORE

 

                         9.1.3.7. THAILAND

 

                         9.1.3.8. MALAYSIA

 

                         9.1.3.9. INDONESIA

 

                         9.1.3.10. PHILIPPINES

 

                         9.1.3.11. REST OF APAC

 

              9.1.4. LATIN AMERICA

 

                         9.1.4.1. BRAZIL

 

                         9.1.4.2. REST OF LATIN AMERICA

 

              9.1.5. MIDDLE EAST AND AFRICA

 

                         9.1.5.1. SOUTH AFRICA

 

                         9.1.5.2. REST OF MIDDLE EAST AND AFRICA

 

9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10. TOPICAL DRUG DELIVERY MARKET: COMPETITIVE LANDSCAPE

            10.1. GLOBAL TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

 

            10.2. U.S. TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

 

            10.3. EUROPE TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

 

            10.4. APAC TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

 

            10.5. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

 

            10.6. MIDDLE EAST AND AFRICA  TOPICAL DRUG DELIVERY MARKET: COMPANY SHARE ANALYSIS

 

            10.7. MERGERS & ACQUISITIONS

 

            10.8. NEW PRODUCT DEVELOPMENT & APPROVALS

 

            10.10. EXPANSIONS

 

            10.10. REGULATORY CHANGES

 

            10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

 

11. TOPICAL DRUG DELIVERY MARKET, COMPANY PROFILES

          11.1. JANSSEN PHARMACEUTICALS, INC. (A J&J COMPANY)

 

                     11.1.1. COMPANY OVERVIEW

 

                     11.1.2. SWOT ANALYSIS

 

                     11.1.3. REVENUE ANALYSIS

 

                     11.1.4. PRODUCT PORTFOLIO

 

                     11.1.5. RECENT DEVELOPEMENTS

 

                     11.1.5. DATA BRIDGE ANALYSIS

 

         11.2. CRESCITA THERAPEUTICS

 

                    11.2.1. COMPANY OVERVIEW

 

                    11.2.2. SWOT ANALYSIS

 

                    11.2.3. REVENUE ANALYSIS

 

                    11.2.4. PRODUCT PORTFOLIO

 

                    11.2.5. RECENT DEVELOPEMENTS

 

                    11.2.5. DATA BRIDGE ANALYSIS

 

         11.3. GALDERMA S.A.

 

                    11.3.1. COMPANY OVERVIEW

 

                    11.3.2. SWOT ANALYSIS

 

                    11.3.3. REVENUE ANALYSIS

 

                    11.3.4. PRODUCT PORTFOLIO

 

                    11.3.5. RECENT DEVELOPEMENTS

 

                    11.3.6. DATA BRIDGE ANALYSIS

 

         11.4. BIOFARMITALIA S.R.L

 

                    11.4.1. COMPANY OVERVIEW

 

                    11.4.2. SWOT ANALYSIS

 

                    11.4.3. REVENUE ANALYSIS

 

                    11.4.4. PRODUCT PORTFOLIO

 

                    11.4.5. RECENT DEVELOPEMENTS

 

                    11.4.5. DATA BRIDGE ANALYSIS

 

         11.5. PHARMATEK LABORATORIES, INC.

 

                    11.5.1. COMPANY OVERVIEW

 

                    11.5.2. SWOT ANALYSIS

 

                    11.5.3. REVENUE ANALYSIS

 

                    11.5.4. PRODUCT PORTFOLIO

 

                    11.5.5. RECENT DEVELOPEMENTS

 

                    11.5.5. DATA BRIDGE ANALYSIS

 

         11.6. STIEFEL LABORATORIES, INC.

 

                    11.6.1. COMPANY OVERVIEW

 

                    11.6.2. SWOT ANALYSIS

 

                    11.6.3. REVENUE ANALYSIS

 

                    11.6.4. PRODUCT PORTFOLIO

 

                    11.6.5. RECENT DEVELOPEMENTS

 

                    11.6.5. DATA BRIDGE ANALYSIS

 

         11.7. TAPEMARK

 

                    11.7.1. COMPANY OVERVIEW

 

                    11.7.2. SWOT ANALYSIS

 

                    11.7.3. REVENUE ANALYSIS

 

                    11.7.4. PRODUCT PORTFOLIO

 

                    11.7.5. RECENT DEVELOPEMENTS

 

                    11.7.6. DATA BRIDGE ANALYSIS

 

         11.8. NITTO DENKO CORPORATION

 

                    11.8.1. COMPANY OVERVIEW

 

                    11.8.2. SWOT ANALYSIS

 

                    11.8.3. REVENUE ANALYSIS

 

                    11.8.4. PRODUCT PORTFOLIO

 

                    11.8.5. RECENT DEVELOPEMENTS

 

                    11.8.6. DATA BRIDGE ANALYSIS

 

         11.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

 

                    11.9.1. COMPANY OVERVIEW

 

                    11.9.2. SWOT ANALYSIS

 

                    11.9.3. REVENUE ANALYSIS

 

                    11.9.4. PRODUCT PORTFOLIO

 

                    11.9.5. RECENT DEVELOPEMENTS

 

                    11.9.6. DATA BRIDGE ANALYSIS

 

         11.9. MYLAN PHARMACEUTICALS INC.

 

                    11.9.1. COMPANY OVERVIEW

 

                    11.9.2. SWOT ANALYSIS

 

                    11.9.3. REVENUE ANALYSIS

 

                    11.9.4. PRODUCT PORTFOLIO

 

                    11.9.5. RECENT DEVELOPEMENTS

 

                    11.9.6. DATA BRIDGE ANALYSIS

 

         11.9. HISAMITSU PHARMACEUTICAL CO., INC.

 

                     11.9.1. COMPANY OVERVIEW

 

                     11.9.2. SWOT ANALYSIS

 

                     11.9.3. REVENUE ANALYSIS

 

                     11.9.4. PRODUCT PORTFOLIO

 

                     11.9.5. RECENT DEVELOPEMENTS

 

                     11.9.5. DATA BRIDGE ANALYSIS

 

         11.10. THERASOLVE NV.

 

                       11.10.1. COMPANY OVERVIEW

 

                       11.10.2. SWOT ANALYSIS

 

                       11.10.3. REVENUE ANALYSIS

 

                       11.10.4. PRODUCT PORTFOLIO

 

                       11.10.5. RECENT DEVELOPEMENTS

 

                       11.10.6. DATA BRIDGE ANALYSIS

 

         11.11. SAMYANG BIOPHARMACEUTICALS CORPORATION

 

                       11.11.1. COMPANY OVERVIEW

 

                       11.11.2. SWOT ANALYSIS

 

                       11.11.3. REVENUE ANALYSIS

 

                       11.11.4. PRODUCT PORTFOLIO

 

                       11.11.5. RECENT DEVELOPEMENTS

 

                       11.11.6. DATA BRIDGE ANALYSIS

 

         11.12. LOHMANN THERAPIE-SYSTEME AG

 

                       11.12.1. COMPANY OVERVIEW

 

                       11.12.2. SWOT ANALYSIS

 

                       11.12.3. REVENUE ANALYSIS

 

                       11.12.4. PRODUCT PORTFOLIO

 

                       11.12.5. RECENT DEVELOPEMENTS

 

                       11.12.6. DATA BRIDGE ANALYSIS

 

         11.13. PROSOLLUS PHARMACEUTICALS

 

                       11.13.1. COMPANY OVERVIEW

 

                       11.13.2. SWOT ANALYSIS

 

                       11.13.3. REVENUE ANALYSIS

 

                       11.13.4. PRODUCT PORTFOLIO

 

                       11.13.5. RECENT DEVELOPEMENTS

 

                       11.13.6. DATA BRIDGE ANALYSIS

 

         11.14. EASTON PHARMACEUTICALS INC.

 

                       11.14.1. COMPANY OVERVIEW

 

                       11.14.2. SWOT ANALYSIS

 

                       11.14.3. REVENUE ANALYSIS

 

                       11.14.4. PRODUCT PORTFOLIO

 

                       11.14.5. RECENT DEVELOPEMENTS

 

                       11.14.6. DATA BRIDGE ANALYSIS

 

         11.15. ANTARES PHARMA, INC.

 

                       11.15.1. COMPANY OVERVIEW

 

                       11.15.2. SWOT ANALYSIS

 

                       11.15.3. REVENUE ANALYSIS

 

                       11.15.4. PRODUCT PORTFOLIO

 

                       11.15.5. RECENT DEVELOPEMENTS

 

                      11.15.6. DATA BRIDGE ANALYSIS

 

         11.16. ENDO PHARMACEUTICALS INC.

 

                       11.16.1. COMPANY OVERVIEW

 

                       11.16.2. SWOT ANALYSIS

 

                       11.16.3. REVENUE ANALYSIS

 

                       11.16.4. PRODUCT PORTFOLIO

 

                       11.16.5. RECENT DEVELOPEMENTS

 

                       11.16.6. DATA BRIDGE ANALYSIS

 

         11.17. TRANSDERMAL TECHNOLOGIES, INC.

 

                       11.17.1. COMPANY OVERVIEW

 

                       11.17.2. SWOT ANALYSIS

 

                       11.17.3. REVENUE ANALYSIS

 

                       11.17.4. PRODUCT PORTFOLIO

 

                       11.17.5. RECENT DEVELOPEMENTS

 

                       11.17.6. DATA BRIDGE ANALYSIS

 

         11.18. SHEFFIELD PHARMACEUTICALS, INC.

 

                       11.18.1. COMPANY OVERVIEW

 

                       11.18.2. SWOT ANALYSIS

 

                       11.18.3. REVENUE ANALYSIS

 

                       11.18.4. PRODUCT PORTFOLIO

 

                       11.18.5. RECENT DEVELOPEMENTS

 

                       11.18.6. DATA BRIDGE ANALYSIS

 

         11.19. SOLVAY

 

                       11.19.1. COMPANY OVERVIEW

 

                       11.19.2. SWOT ANALYSIS

 

                       11.19.3. REVENUE ANALYSIS

 

                       11.19.4. PRODUCT PORTFOLIO

 

                       11.19.5. RECENT DEVELOPEMENTS

 

                       11.19.6. DATA BRIDGE ANALYSIS

 

         11.20. 3M DRUG DELIVERY SYSTEMS

 

                       11.20.1. COMPANY OVERVIEW

 

                       11.20.2. SWOT ANALYSIS

 

                       11.20.3. REVENUE ANALYSIS

 

                       11.20.4. PRODUCT PORTFOLIO

 

                       11.20.5. RECENT DEVELOPEMENTS

 

                       11.20.6. DATA BRIDGE ANALYSIS

 

12. APPENDIX

13. ABOUT DATA BRIDGE MARKET RESEARCH

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Related Reports:

Global Radiopharmaceuticals Market – Industry Trends and Forecast to 2024

By Type (Diagnostic, Therapeutic), Procedural Volumes (Diagnostic Procedures, Therapeutic Procedures), Application, Sources (Nuclear Reactors, Cyclotrons), End User, Geography (North America, Europe, APAC, South America, MEA)– Industry Trends andForecast To 2024

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Varsha Chaudhari
Email: Send Email
Phone: +1-888-387-2818
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market-trends-forecast-2024/

Calendar

August 2017
M T W T F S S
« Jul    
 123456
78910111213
14151617181920
21222324252627
28293031